Iongen Therapeutics

Iongen Therapeutics is a biotechnology company focused on developing novel, non-opioid treatments for chronic pain by targeting specific ion channels in the peripheral nervous system. Founded by leading neuroscientists from Harvard Medical School, the company utilizes a proprietary drug discovery platform to identify small molecules that selectively silence pain-sensing neurons (nociceptors). Their research aims to address the significant unmet need for effective pain management without the side effects and addiction risks associated with traditional analgesics. Iongen is backed by prominent life science investors and operates out of the Boston biotechnology hub.